FMK 9a is an irreversible inhibitor of ATG4B with IC50 values of 80 and 73 nM in the TR-FRET and cellular-based LRA assays.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 6-8 weeks | $ 212 | |
2 mg | 6-8 weeks | $ 402 | |
4 mg | 6-8 weeks | $ 571 | |
10 mg | 6-8 weeks | $ 1053 | |
20 mg | 6-8 weeks | $ 1632 |
Description | FMK 9a is an irreversible inhibitor of ATG4B with IC50 values of 80 and 73 nM in the TR-FRET and cellular-based LRA assays. |
Targets&IC50 | autophagin-1, FRET assay:80 nM, autophagin-1, LRA assay:73 nM |
In vitro | FMK 9a forms a covalent bond with the more reactive thiol group of Cys74 located at the catalytic site of ATG4B thereby inactivating ATG4B proteolytic activity. |
In vivo | FMK 9a shows moderate solubility and high liver microsome clearances for human and mice of 13.9 and 70 mL/kg/min. |
CAS No. | 1955550-51-2 |
Chemical Formula | C23H21FN2O3 |
Molecular Weight | 392.43 |
Solubility | DMSO: 95 mg/mL (242.09 mM), Need ultrasonic |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom